Clarity Pharmaceuticals Ltd reported earnings results for the half year ended December 31, 2023. For the half year, the company reported revenue was AUD 6.52 million compared to AUD 6.38 million a year ago. Net loss was AUD 17.2 million compared to AUD 11.24 million a year ago.

Basic loss per share from continuing operations was AUD 0.066 compared to AUD 0.043 a year ago. Diluted loss per share from continuing operations was AUD 0.066 compared to AUD 0.043 a year ago.